Anzeige
Mehr »
Dienstag, 12.08.2025 - Börsentäglich über 12.000 News
Diese Aktie liegt in der Turbo-Zone - und könnte der Gold-Gewinner 2025/26 werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14.07.UK project addresses capacity issue in CGT manufacturing
14.07.Takeda's narcolepsy programme gets back on track
14.07.AZ prepares to file blood pressure drug after trial win
14.07.Bayer gets sought-after heart failure use for Kerendia
14.07.Paper gives hint of Apple's thinking on AI and health
11.07.Case builds for Biogen, Stoke's Dravet syndrome drug
11.07.AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody
11.07.Bayer bags first world approval for hot flush therapy
11.07.Cash injection will help Varda make drugs in space
10.07.Just how radical is the FDA's complete response letter move?
10.07.EU President fends off no-confidence vote over Pfizer texts
10.07.'Diabetes Barbie' launches with medtech accessories
10.07.UK authority cracks down on weight-loss drug ads
10.07.US measles elimination status at risk as cases soar
10.07.NICE backs new drugs for Crohn's disease, lymphoma
09.07.FDA clears new, safer regimen for Lilly's Alzheimer's drug
09.07.Concentra throws lifeline to troubled CARGO Therapeutics
09.07.Update: MSD confirms $10bn takeover deal for Verona Pharma
09.07.Novo Nordisk files high-dose Wegovy in EU
09.07.Is MSD preparing a $10bn deal to buy Verona Pharma?
09.07.New radiopharma Actithera emerges with $75.5m in financing
08.07.Taiho's late-stage Duchenne candidate fails trial
08.07.Boehringer raises hope of oral drug for diabetic eye disease
08.07.First malaria drug for newborns and young infants cleared
08.07.Medical groups sue RFK Jr over COVID-19 policies